IM Cannabis (IMCC) Long-Term Investments (2019 - 2024)
IM Cannabis' (IMCC) quarterly Long-Term Investments came in at $1.7 million in Q3 2024, up 1.84% year-on-year from $1.6 million in Q4 2023, and little changed quarter-over-quarter from $1.7 million in Q2 2024.
IM Cannabis (IMCC) Long-Term Investments (2019 - 2024) Analysis & Trends
IM Cannabis' Long-Term Investments history runs 6 years deep, the most recent figure standing at $1.7 million for Q3 2024.
- On a quarterly basis, Long-Term Investments rose 1.84% year-over-year to $1.7 million in Q3 2024; TTM through Sep 2024 was $1.7 million, a 1.84% increase from a year earlier, with the FY2023 full-year figure at $1.7 million, down 8.64% from the prior year.
- Long-Term Investments held at $1.7 million in Q3 2024 per IMCC's latest filing, from $1.7 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $2.9 million in Q2 2021 and bottomed at -$1.0 million in Q4 2020.
- The 5-year median for Long-Term Investments is $1.8 million (2022), against an average of $1.7 million.
- Across the five-year window, Long-Term Investments plunged 702.56% in 2020 and surged 286.51% in 2021, its largest moves.
- Year by year, Long-Term Investments stood at -$1.0 million in 2020, then jumped by 286.51% to $1.9 million in 2021, then slipped by 7.86% to $1.8 million in 2022, then decreased by 5.47% to $1.7 million in 2023, then decreased by 0.33% to $1.7 million in 2024.
- Per Business Quant, the three latest IMCC Long-Term Investments figures stand at $1.7 million (Q3 2024), $1.7 million (Q2 2024), and $1.5 million (Q1 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 56.09 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.32 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 702.35 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 146.10 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | IM Cannabis | 591,792.44 | -193,562.09 | 1.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Sep 30, 2021 | 1.86 Mn |
| Jun 30, 2021 | 2.89 Mn |
| Mar 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | -1.03 Mn |
| Dec 31, 2019 | 171,473.39 |